From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

The 81,000-square-foot facility will enhance the health system's cancer care offerings in the UK, with completion expected in ...

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...

Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of ...

Changes in ctDNA can predict long-term outcomes in certain patients with metastatic CRC on immune checkpoint inhibitors.

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...